{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:54:21Z","timestamp":1778561661387,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jiac.2018.07.011","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T19:17:27Z","timestamp":1533669447000},"page":"147-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The development of diffuse panbronchiolitis during the treatment with long-term, low-dose clarithromycin for chronic sinusitis"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-6422","authenticated-orcid":false,"given":"Masaru","family":"Ando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Usagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Tokimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2018.07.011_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.83.1.63","article-title":"Diffuse panbronchiolitis. A disease of the transitional zone of the lung","volume":"83","author":"Homma","year":"1983","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2018.07.011_bib2","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl.\u00a09A","key":"10.1016\/j.jiac.2018.07.011_bib3","first-page":"12S","article-title":"Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases","volume":"117","author":"Kudoh","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jiac.2018.07.011_bib4","series-title":"Revision of clinical guidelines for diffuse panbronchiolitis. Grant-in aid from the Ministry of Health and Welfare of Japan. Tokyo","first-page":"109","author":"Nakata","year":"1998"},{"key":"10.1016\/j.jiac.2018.07.011_bib5","first-page":"442","article-title":"Problems in chronic obstructive bronchial diseases, with special reference to diffuse panbronchiolitis","volume":"23","author":"Yamanaka","year":"1969","journal-title":"Naika"},{"key":"10.1016\/j.jiac.2018.07.011_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.11150\/kansenshogakuzasshi1970.69.711","article-title":"Study on azithromycin in treatment of diffuse panbronchiolitis","volume":"69","author":"Kobayashi","year":"1995","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.jiac.2018.07.011_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1440-1843.2007.01208.x","article-title":"Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid","volume":"13","author":"Kikuchi","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.jiac.2018.07.011_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/rccm.200212-1437OC","article-title":"In\u00a0vivo and in\u00a0vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells","volume":"168","author":"Shimizu","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2018.07.011_bib9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.imbio.2012.10.014","article-title":"Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia","volume":"218","author":"Cai","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.jiac.2018.07.011_bib10","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/AAC.42.7.1578","article-title":"Oral cimetidine prolongs clarithromycin absorption","volume":"42","author":"Amsden","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.07.011_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/ppul.1076","article-title":"Anti-inflammatory effects of macrolides in lung disease","volume":"31","author":"Jaffe","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jiac.2018.07.011_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2001.tb10917.x","article-title":"Macrolide antibiotics and pulmonary inflammation","volume":"205","author":"Hoyt","year":"2001","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jiac.2018.07.011_bib13","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1128\/iai.62.10.4145-4152.1994","article-title":"Role of Interleukin-8 (Il-8) and an inhibitory effect of erythromycin on Il-8 release in the airways of patients with chronic airway diseases","volume":"62","author":"Oishi","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.jiac.2018.07.011_bib14","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1378\/chest.104.4.1191","article-title":"Anti-inflammatory action of erythromycin. Its inhibitory effect on neutrophil nadph oxidase activity","volume":"104","author":"Umeki","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2018.07.011_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1164\/ajrccm\/147.1.153","article-title":"A\u00a0mechanism of erythromycin treatment in patients with diffuse panbronchiolitis","volume":"147","author":"Kadota","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jiac.2018.07.011_bib16","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.7164\/antibiotics.46.1406","article-title":"Antilymphocytic activity of erythromycin distinct from that of Fk506 or cyclosporin a","volume":"46","author":"Keicho","year":"1993","journal-title":"J\u00a0Antibiot (Tokyo)"},{"key":"10.1016\/j.jiac.2018.07.011_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.7164\/antibiotics.47.80","article-title":"Erythromycin promotes monocyte to macrophage differentiation","volume":"47","author":"Keicho","year":"1994","journal-title":"J\u00a0Antibiot (Tokyo)"},{"key":"10.1016\/j.jiac.2018.07.011_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1164\/ajrccm\/141.1.72","article-title":"Erythromycin inhibits respiratory glycoconjugate secretion from human airways in\u00a0vitro","volume":"141","author":"Goswami","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jiac.2018.07.011_bib19","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"Kanoh","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2018.07.011_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0954-6111(03)00042-8","article-title":"Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis","volume":"97","author":"Kadota","year":"2003","journal-title":"Respir Med"},{"key":"10.1016\/j.jiac.2018.07.011_bib21","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2169\/internalmedicine.50.4727","article-title":"Effect of azithromycin on patients with diffuse panbronchiolitis: retrospective study of 51 cases","volume":"50","author":"Li","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2018.07.011_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2500\/105065800782102717","article-title":"Macrolide treatment decreased the size of nasal polyps and Il-8 levels in nasal lavage","volume":"14","author":"Yamada","year":"2000","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jiac.2018.07.011_bib23","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1164\/ajrccm.155.6.9196110","article-title":"Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis","volume":"155","author":"Rubin","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2018.07.011_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1067\/mhn.2002.124849","article-title":"One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide","volume":"126","author":"Cervin","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jiac.2018.07.011_bib25","first-page":"19","article-title":"Historical changes in epidemiology of diffuse panbronchiolitis","volume":"29","author":"Kono","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.jiac.2018.07.011_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijantimicag.2003.07.002","article-title":"Protekt 1999-2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea","volume":"23","author":"Inoue","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl.\u00a0A","key":"10.1016\/j.jiac.2018.07.011_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/27.suppl_A.117","article-title":"A\u00a0comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia","volume":"27","author":"Anderson","year":"1991","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2018.07.011_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/resp.12412","article-title":"Nontuberculous mycobacteria in diffuse panbronchiolitis","volume":"20","author":"Tsuji","year":"2015","journal-title":"Respirology"},{"key":"10.1016\/j.jiac.2018.07.011_bib29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.7326\/0003-4819-121-12-199412150-00001","article-title":"Clarithromycin therapy for bacteremic Mycobacterium Avium complex disease. A randomized, double-blind, dose-ranging study in patients with aids. Aids clinical trials group protocol 157 study team","volume":"121","author":"Chaisson","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2018.07.011_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1128\/AAC.38.2.381","article-title":"Identification of mutations in 23s rrna gene of clarithromycin-resistant Mycobacterium intracellulare","volume":"38","author":"Meier","year":"1994","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18302289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18302289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:57:31Z","timestamp":1761159451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X18302289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1341321X18302289"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2018.07.011","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The development of diffuse panbronchiolitis during the treatment with long-term, low-dose clarithromycin for chronic sinusitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2018.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}